Clinical Trials Browser

INDUSTRY × Ovarian Neoplasms × lorvotuzumab mertansine × Clear all

NCT00346385 2015-03-26

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

DermatologicGynecologicThoracic

Ovarian Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma